Literature DB >> 1114894

Oxidation of glucose and D-B-OH-butyrate by the early human fetal brain.

P A Adam, N Räihä, E L Rahiala, M Kekomäki.   

Abstract

The isolated brains of 12 previable human fetuses obtained at 12 to 21 weeks' gestation, were perfused through the interval carotid artery with glucose (3 mM) and/or DL-B-OH-butyrate (DL-BOHB), 4.5 MM, plus tracer quantities of either glucose-6-14C (G6-14C) or beta-OH-butyrate-3-14C (BOHB3-14C). Oxidative metabolism was demonstrated by serial collection of gaseous 14CO2 from the closed perfusion system, and from the recirculating medium. Glucose and BOHB were utilized at physiological rates as indicated (mean plus or minus SEM): G6-14C at 0.10 plus or minus 0.01 mumoles/min g brain (n equal 7) or 17.5 plus or minus 1.9 mumoles/min kg fetus; and BOHB3-14C at 0.16 plus or minus 0.05 mumoles/min g (n equal to 5) or 27.3 plus or minus 7.4 mumoles/min kg. Based on fetal weight, glucose metabolism by brain apparently accounted for about 1/3 of basal glucose utilization in the fetus. On a molar basis BOHB3-14C was taken up at 1.47 times the rate of G6-14C. Both BOHB3-14C and G6 14C were converted to 14CO2. The rate of BOHB3-14C conversion to 14CO2 was equal to its rate of consumption, and exceeded the conversion of glucose to CO2 because 45% of the G6-14C was incorporated into lactate-14C. Accordingly, both substrates support oxidative metabolism by brain; and BOHB is a major potential alternate fuel which can replace glucose early in human development.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1114894     DOI: 10.1111/j.1651-2227.1975.tb04375.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  11 in total

Review 1.  Hypoglycaemia of the newborn: a review.

Authors:  A F Williams
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 2.  Hypoglycemia in newborn infants.

Authors:  K C King
Journal:  Indian J Pediatr       Date:  1982 Sep-Oct       Impact factor: 1.967

Review 3.  Lipid metabolism in pregnancy and its consequences in the fetus and newborn.

Authors:  Emilio Herrera
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

4.  Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria.

Authors:  S Krahenbuhl; D B Ray; S P Stabler; R H Allen; E P Brass
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 5.  Why is carbon from some polyunsaturates extensively recycled into lipid synthesis?

Authors:  Stephen C Cunnane; Mary Ann Ryan; Chantale R Nadeau; Richard P Bazinet; Kathy Musa-Veloso; Ursula McCloy
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

6.  Ketone body transport in the human neonate and infant.

Authors:  P F Bougneres; C Lemmel; P Ferré; D M Bier
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  Prevention of neonatal hypoglycaemia by oral lipid supplementation in low birth weight infants.

Authors:  L Sann; B Mousson; M Rousson; I Maire; M Bethenod
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 8.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

Review 9.  Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.

Authors:  Matthew K Taylor; Russell H Swerdlow; Debra K Sullivan
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

10.  Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease.

Authors:  Stephen C Cunnane; Alexandre Courchesne-Loyer; Camille Vandenberghe; Valérie St-Pierre; Mélanie Fortier; Marie Hennebelle; Etienne Croteau; Christian Bocti; Tamas Fulop; Christian-Alexandre Castellano
Journal:  Front Mol Neurosci       Date:  2016-07-08       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.